| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
2e-14 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-11 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-10 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-09 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-08 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-08 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |